Eirion Therapeutics, Inc. Closes $40 Million Series A Investment and Licensing Deal with Shanghai Haohai Biological Technology Ltd.

from Venture Capital Access Online: Latest Venture Capital and Private Equity News https://ift.tt/3chDf5N
via IFTTT